Overview

• Healthcare-at-home provider's Q4 revenue beat analyst expectations

• Q4 operating loss and pretax loss wider than analyst expectations

• Company expanded footprint by acquiring HME provider in Hawaii

Outlook

• AdaptHealth forecasts 2026 net revenue between $3.44 bln and $3.51 bln

• Company expects 2026 adjusted EBITDA of $680 mln to $730 mln

• AdaptHealth projects 2026 free cash flow of $175 mln to $225 mln

Result Drivers

• PATIENT GROWTH - AdaptHealth set new patient census records in Sleep Health, Respiratory Health, and Wellness at Home

• GEOGRAPHIC EXPANSION - Acquired a leading HME provider in Hawaii, expanding the company's footprint to its 48th state

• DIGITAL ENGAGEMENT - More than doubled myApp users to 327,300, enhancing digital patient engagement

Company press release: ID:nBw8nk0Wma

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

• Wall Street's median 12-month price target for Adapthealth Corp is $13.00, about 26.3% above its February 23 closing price of $10.29

• The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 8 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)